Expression of ROR1 in patients with renal cancer-A potential diagnostic marker

Iranian Biomedical Journal

Volumn 14, Issue 3, 2010, Pages 77-82

  Rabbani, Hodjattallah ^a,b   Ostadkarampour, Mahyar ^a   Manesh, Amir Hossein Danesh ^b   Basiri, Abbas ^c   Jeddi Tehrani, Mahmood ^a   Forouzesh, Flora ^a,d  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Ectopic expression; Renal cancer; ROR1

Indexed keywords

PHOSPHOGLUCOMUTASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE ROR1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; KIDNEY CANCER; MALE; PAPILLARY CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEALTH; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOGLUCOMUTASE; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 78649583246     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lidgren, A., Hedberg, Y., Grankvist, K., Rasmuson, T., Vasko J., and Ljungberg B. (2005) The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin. Cancer Res. 11: 1129-1135.
2. Linehan, W.M., Walther, M.M. and Zbar, B. (2003) The genetic basis of cancer of the kidney. J. Urol. 170: 2163-2172.
3. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J.P., Zelnik, V., Opavsky, R., Zatovicova, M., Liao, S., Portetelle, D., Stanbridge, E.J., Zavada, J., Burny, A. and Kettmann, R. (1994) Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9: 2877-2888.
4. Shabani, M., Asgarian-Omran, H., Vossough, P., Ramazan, A., Sharifian, R.A., Faranoush, M., Ghragozlou, S., Khoshnoodi, J., Roohi, A., Jeddi- Tehrani, M., Mellstedt, H., Rabbani, H. and Shokri, F. (2008) Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia. Leuk. Lymphoma. 49: 1360-1367.
5. Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J.E., Widhopf, G.F., Rassenti, L.Z., Cantwell, M.J., Prussak, C.E., Dennis, A., Carson, D.A. and Kipps, T.J. (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc. Natl. Acad. Sci. USA 105 (8): 3047-3052.
6. Daneshmanesh, A.H., Mikaelsson, E., Jeddi-Tehrani, M., Bayat, A.A., Ghods, R., Ostadkarampour, M., Akhondi, M., Lagererantz, S., Larsson, C., Osterborg, A., Shokri, F., Mellstedt, H. and Rabbani, H. (2008) Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. Int. J. Cancer 123: 1190-1195.
7. Baskar, S., Kwong, K.Y., Hofer, T., Levy, J.M., Kennedy, M.G., Lee, E., Staudt, L.M., Wilson, W.H., Wiestner, A. and Rader, C. (2008) Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clin. Cancer Res. 14: 396-404.
8. Shabani, M., Asgarian-Omran, H., Jeddi-Tehrani, M., Vossough, P., Faranoush, M., Sharifian, R.A., Toughe, G.R., Kordmahin, M., Khoshnoodi, J., Roohi, A., Tavoosi, N., Mellstedt, H., Rabbani, H. and Shokri, F. (2007) Over expression of orphan receptor tyrosine kinase Ror1 as a putative tumorassociated antigen in Iranian patients with acute lymphoblastic leukemia. Tumour Biol. 28: 318-326.
9. MacKeigan, J.P., Murphy, L.O. and Blenis, J. (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell Biol. 7: 591-600.
10. Matsuda, T., Nomi, M., Ikeya, M., Kani, S., Oishi, I., Terashima, T., Takada, S. and Minami, Y. (2001) Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech. Dev. 105: 153-156.
11. Green, J.L., Kuntz, S.G. and Sternberg, P.W. (2008) Ror receptor tyrosine kinases: orphans no more. Trends Cell Biol. 18: 536-544.
12. Reddy, U.R., Phatak, S., Allen, C., Nycum, L.M., Sulman, E.P., White, P.S. and Biegel, J.A. (1997) Localization of the human Ror1 gene (NTRKR1) to chromosome 1p31-p32 by fluorescence in situ hybridization and somatic cell hybrid analysis. Genomics 41: 283-285.
13. Masiakowski, P. and Carroll, R.D. (1992) A novel family of cell surface receptors with tyrosine kinaselike domain. J. Biol. Chem. 267: 26181-26190.
14. Forrester, W.C. (2002) The Ror receptor tyrosine kinase family. Cell. Mol. Life Sci. 59: 83-96.
15. Reddy, U.R., Phatak, S. and Pleasure, D. (1996) Human neural tissues express a truncated Ror1 receptor tyrosine kinase, lacking both extracellular and transmembrane domains. Oncogene 13: 1555-1559.
16. Oishi, I., Takeuchi, S., Hashimoto, R., Nagabukuro, A., Ueda, T., Liu, Z.J., Hatta, T., Akira, S., Matsuda, Y., Yamamura, H., Otani, H. and Minami, Y. (1999) Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system. Genes Cells 4: 41-56.
17. Al-Shawi, R., Ashton, S.V., Underwood, C. and Simons, J.P. (2001) Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev. Genes Evol. 211: 161-171.
18. Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila-Carino, J., Osterborg, A., Wigzell, H. and Mellstedt, H. (2000) Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. Br. J. Haematol. 111: 608-617.
19. Hosseini-Asl, S., Modarressi, M.H., Atri, M., Salhab, M., Mokbel, K. and Mehdipou, P. (2006) The association between telomerase activity and expression of its RNA component (hTR) in breast cancer patients: the importance of DNase treatment. J. Carcinog. 5: 17.